Literature DB >> 2037010

Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells.

D Becker1, A B Reske-Kunz, J Knop, K Reske.   

Abstract

The cell surface expression and biosynthesis of Langerhans cells (LC)-derived major histocompatibility complex (MHC) class II molecules from epidermal cells (EC) prepared freshly and cultured for up to 3 days was investigated. Based on the constitutive expression of MHC class II determinants by LC, a panning and magnetic bead selection procedure was employed, yielding 65% and 86% of I-A+ cells, respectively. Phenotypical and cytochemical examinations revealed that the two LC preparations were free of contaminating macrophages as well as B and T cells. Freshly prepared enriched LC were highly efficient in the stimulation of protein antigen-specific T cell clones, while LC purified from short-term cultured EC suspensions proved to be more efficient allogeneic stimulator cells than fresh LC. Comparative analysis of LC obtained from freshly prepared and from short-term-cultured EC preparations indicated an up-regulation of MHC class II determinants during short-term culture. Radioiodination analysis of LC selected by magnetic beads demonstrated prominent class II alpha and beta chain signals with only a minute fraction of invariant chains p35 and p45 being expressed at the cell surface. Unlike class II complexes derived from B cells, those from LC contained invariant chain fragment p20 in association with alpha/beta heterodimers at the plasma membrane. No qualitative differences between freshly isolated and 3-day cultured LC in cell surface expressed MHC class II components were detectable. Metabolic labeling with subsequent two-dimensional electrophoresis revealed distinct features of LC-derived MHC class II molecules with a high proportion of invariant chains in particular gamma and p40 and their extensive sialylation. While fresh and 1-day cultured LC exhibited appreciable levels of newly synthesized class II molecules, a dramatic down-regulation in class II and invariant chain synthesis was measured after 3 days of continuous in vitro culture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2037010     DOI: 10.1002/eji.1830210518

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system.

Authors:  N Romani; G Schuler
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.

Authors:  G Girolomoni; M T Valle; V Zacchi; M G Costa; A Giannetti; F Manca
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

3.  Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.

Authors:  Stephan Sudowe; Sabine Dominitzki; Evelyn Montermann; Matthias Bros; Stephan Grabbe; Angelika B Reske-Kunz
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

4.  In vitro analysis of the phenotypical and functional properties of the 4F7+ cutaneous accessory dendritic cell.

Authors:  M Mohamadzadeh; J Knop; G Kolde
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 5.  Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells.

Authors:  H Moll; U Ritter; S Flohé; K Erb; C Bauer; C Blank
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

6.  Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major.

Authors:  S Flohé; T Lang; H Moll
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Modulation of accessory cell function of immortalized bone marrow-derived macrophages by granulocyte/macrophage colony-stimulating factor.

Authors:  R Zecher; C Scheicher; S Wagener; A B Reske-Kunz; K Reske
Journal:  Med Microbiol Immunol       Date:  1993-07       Impact factor: 3.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.